175 related articles for article (PubMed ID: 37035930)
1. Structure-function relationship and impact on the gut-immune barrier function of non-digestible carbohydrates and human milk oligosaccharides applicable for infant formula.
Chen X; de Vos P
Crit Rev Food Sci Nutr; 2023 Apr; ():1-21. PubMed ID: 37035930
[TBL] [Abstract][Full Text] [Related]
2. Impact of dietary fibers in infant formulas on gut microbiota and the intestinal immune barrier.
Kong C; Faas MM; de Vos P; Akkerman R
Food Funct; 2020 Nov; 11(11):9445-9467. PubMed ID: 33150902
[TBL] [Abstract][Full Text] [Related]
3. Non-digestible carbohydrates in infant formula as substitution for human milk oligosaccharide functions: Effects on microbiota and gut maturation.
Akkerman R; Faas MM; de Vos P
Crit Rev Food Sci Nutr; 2019; 59(9):1486-1497. PubMed ID: 29333864
[TBL] [Abstract][Full Text] [Related]
4. Microbiota from human infants consuming secretors or non-secretors mothers' milk impacts the gut and immune system in mice.
Gurung M; Schlegel BT; Rajasundaram D; Fox R; Bode L; Yao T; Lindemann SR; LeRoith T; Read QD; Simecka C; Carroll L; Andres A; Yeruva L
mSystems; 2024 Apr; 9(4):e0029424. PubMed ID: 38530054
[TBL] [Abstract][Full Text] [Related]
5. Distinct fermentation of human milk oligosaccharides 3-FL and LNT2 and GOS/inulin by infant gut microbiota and impact on adhesion of
Kong C; Akkerman R; Klostermann CE; Beukema M; Oerlemans MMP; Schols HA; de Vos P
Food Funct; 2021 Dec; 12(24):12513-12525. PubMed ID: 34811557
[TBL] [Abstract][Full Text] [Related]
6. Human milk oligosaccharides and infant gut microbiota: Molecular structures, utilization strategies and immune function.
Zhang B; Li LQ; Liu F; Wu JY
Carbohydr Polym; 2022 Jan; 276():118738. PubMed ID: 34823774
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Intestinal Epithelial Glycocalyx Development by Human Milk Oligosaccharides and Non-Digestible Carbohydrates.
Kong C; Elderman M; Cheng L; de Haan BJ; Nauta A; de Vos P
Mol Nutr Food Res; 2019 Sep; 63(17):e1900303. PubMed ID: 31140746
[TBL] [Abstract][Full Text] [Related]
8. Shaping the Infant Microbiome With Non-digestible Carbohydrates.
Verkhnyatskaya S; Ferrari M; de Vos P; Walvoort MTC
Front Microbiol; 2019; 10():343. PubMed ID: 30858844
[TBL] [Abstract][Full Text] [Related]
9. Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro.
Natividad JM; Marsaux B; Rodenas CLG; Rytz A; Vandevijver G; Marzorati M; Van den Abbeele P; Calatayud M; Rochat F
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745275
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal barrier function, immunity, and neurocognition: The role of human milk oligosaccharide (hMO) supplementation in infant formula.
Kassai S; de Vos P
Compr Rev Food Sci Food Saf; 2024 Jan; 23(1):e13271. PubMed ID: 38284595
[TBL] [Abstract][Full Text] [Related]
11. Structure-Specific Fermentation of Galacto-Oligosaccharides, Isomalto-Oligosaccharides and Isomalto/Malto-Polysaccharides by Infant Fecal Microbiota and Impact on Dendritic Cell Cytokine Responses.
Logtenberg MJ; Akkerman R; Hobé RG; Donners KMH; Van Leeuwen SS; Hermes GDA; de Haan BJ; Faas MM; Buwalda PL; Zoetendal EG; de Vos P; Schols HA
Mol Nutr Food Res; 2021 Aug; 65(16):e2001077. PubMed ID: 34060703
[TBL] [Abstract][Full Text] [Related]
12. Functional effects of human milk oligosaccharides (HMOs).
Dinleyici M; Barbieur J; Dinleyici EC; Vandenplas Y
Gut Microbes; 2023; 15(1):2186115. PubMed ID: 36929926
[TBL] [Abstract][Full Text] [Related]
13. Maternal Human Milk Oligosaccharide Profile Modulates the Impact of an Intervention with Iron and Galacto-Oligosaccharides in Kenyan Infants.
Paganini D; Uyoga MA; Kortman GAM; Boekhorst J; Schneeberger S; Karanja S; Hennet T; Zimmermann MB
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31671757
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Oligosaccharides and Glycoconjugates Content in Human Milk and the Development of the Gut Barrier.
Figueroa-Lozano S; de Vos P
Compr Rev Food Sci Food Saf; 2019 Jan; 18(1):121-139. PubMed ID: 33337019
[TBL] [Abstract][Full Text] [Related]
15. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.
Berger B; Porta N; Foata F; Grathwohl D; Delley M; Moine D; Charpagne A; Siegwald L; Descombes P; Alliet P; Puccio G; Steenhout P; Mercenier A; Sprenger N
mBio; 2020 Mar; 11(2):. PubMed ID: 32184252
[TBL] [Abstract][Full Text] [Related]
16. Combining galacto-oligosaccharides and 2'-fucosyllactose alters their fermentation kinetics by infant fecal microbiota and influences AhR-receptor dependent cytokine responses in immature dendritic cells.
Akkerman R; Logtenberg MJ; Beukema M; de Haan BJ; Faas MM; Zoetendal EG; Schols HA; de Vos P
Food Funct; 2022 Jun; 13(12):6510-6521. PubMed ID: 35642586
[TBL] [Abstract][Full Text] [Related]
17. Across the "Sweetest" Properties of Human Breast Milk: Focus on Oligosaccharides.
Bardanzellu F; Reali A; Marcialis MA; Fanos V
Curr Pediatr Rev; 2020; 16(4):255-264. PubMed ID: 32348229
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of human milk oligosaccharides on gut microbiota.
Musilova S; Rada V; Vlkova E; Bunesova V
Benef Microbes; 2014 Sep; 5(3):273-83. PubMed ID: 24913838
[TBL] [Abstract][Full Text] [Related]
19. More than sugar in the milk: human milk oligosaccharides as essential bioactive molecules in breast milk and current insight in beneficial effects.
Cheng L; Akkerman R; Kong C; Walvoort MTC; de Vos P
Crit Rev Food Sci Nutr; 2021; 61(7):1184-1200. PubMed ID: 32329623
[TBL] [Abstract][Full Text] [Related]
20. An Expert Panel Statement on the Beneficial Effects of Human Milk Oligosaccharides (HMOs) in Early Life and Potential Utility of HMO-Supplemented Infant Formula in Cow's Milk Protein Allergy.
Sekerel BE; Bingol G; Cullu Cokugras F; Cokugras H; Kansu A; Ozen H; Tamay Z
J Asthma Allergy; 2021; 14():1147-1164. PubMed ID: 34594114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
